Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.45 Million shares of MRNA, which is worth approximately $37.1 Million. The most recent transaction as insider was on Nov 29, 2023, when has been sold 1,136 shares (Common Stock) at a price of $79.81 per share, resulting in proceeds of $90,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M

0.1% 3M change

0.34% 12M change

Total Value Held $37.1 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2023	SELL Open market or private sale	$90,664 $79.81 p/Share	1,136 Reduced 0.07%	1,575,721 Common Stock
Nov 28 2023	BUY Exercise of conversion of derivative security	-	2,411 Added 0.15%	1,576,857 Common Stock
Nov 10 2023	SELL Open market or private sale	$18,083 $68.76 p/Share	263 Reduced 0.02%	1,574,446 Common Stock
Nov 09 2023	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,574,709 Common Stock
Sep 15 2023	SELL Open market or private sale	$1,694,850 $112.99 p/Share	15,000 Reduced 0.94%	1,574,187 Common Stock
Sep 05 2023	SELL Open market or private sale	$35,660 $111.44 p/Share	320 Reduced 0.02%	1,589,187 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	652 Added 0.04%	1,589,507 Common Stock
Aug 29 2023	SELL Open market or private sale	$130,536 $115.01 p/Share	1,135 Reduced 0.07%	1,588,855 Common Stock
Aug 28 2023	BUY Exercise of conversion of derivative security	-	2,411 Added 0.15%	1,589,990 Common Stock
Aug 17 2023	SELL Open market or private sale	$1,500,000 $100.0 p/Share	15,000 Reduced 0.94%	1,587,579 Common Stock
Aug 10 2023	SELL Open market or private sale	$25,324 $102.53 p/Share	247 Reduced 0.02%	1,602,579 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	-	523 Added 0.03%	1,602,826 Common Stock
Jul 17 2023	SELL Open market or private sale	$1,809,000 $120.6 p/Share	15,000 Reduced 0.93%	1,602,303 Common Stock
Jun 15 2023	SELL Open market or private sale	$1,888,950 $125.93 p/Share	15,000 Reduced 0.92%	1,617,303 Common Stock
Jun 02 2023	SELL Open market or private sale	$40,268 $130.32 p/Share	309 Reduced 0.02%	1,632,303 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	651 Added 0.04%	1,632,612 Common Stock
May 30 2023	SELL Open market or private sale	$147,565 $124.95 p/Share	1,181 Reduced 0.07%	1,631,961 Common Stock
May 26 2023	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,633,142 Common Stock
May 10 2023	SELL Open market or private sale	$33,342 $133.37 p/Share	250 Reduced 0.02%	1,630,732 Common Stock
May 09 2023	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,630,982 Common Stock
Mar 02 2023	SELL Open market or private sale	$160,578 $136.43 p/Share	1,177 Reduced 0.07%	1,630,460 Common Stock
Mar 01 2023	SELL Open market or private sale	$147,968 $138.03 p/Share	1,072 Reduced 0.07%	1,629,031 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	2,606 Added 0.16%	1,631,637 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,630,103 Common Stock
Feb 10 2023	SELL Open market or private sale	$40,155 $163.9 p/Share	245 Reduced 0.02%	1,627,693 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account